These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34665027)

  • 1. Difluprednate-Hydroxypropyl-β-Cyclodextrin-Based Ophthalmic Solution for Improved Delivery in a Porcine Eye Model.
    Shelley H; Annaji M; Smith FT; Babu RJ
    J Ocul Pharmacol Ther; 2022; 38(1):92-101. PubMed ID: 34665027
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved Ocular Delivery of Nepafenac by Cyclodextrin Complexation.
    Shelley H; Grant M; Smith FT; Abarca EM; Jayachandra Babu R
    AAPS PharmSciTech; 2018 Aug; 19(6):2554-2563. PubMed ID: 29948988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation.
    Wang F; Yu W; Popescu C; Ibrahim AA; Yu D; Pearson R; MacKerell AD; Hoag SW
    Pharm Dev Technol; 2022 Apr; 27(4):389-398. PubMed ID: 35468028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
    Verhoeven RS; Garcia A; Robeson R; Gilger BC; Culp D; Struble C; Hamm L; Navratil T; Yerxa B
    J Ocul Pharmacol Ther; 2018; 34(1-2):161-169. PubMed ID: 28650720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Korenfeld MS; Silverstein SM; Cooke DL; Vogel R; Crockett RS;
    J Cataract Refract Surg; 2009 Jan; 35(1):26-34. PubMed ID: 19101421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.
    Mihajlovic T; Kachrimanis K; Graovac A; Djuric Z; Ibric S
    AAPS PharmSciTech; 2012 Jun; 13(2):623-31. PubMed ID: 22535520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complex of saikosaponin-d with hydroxypropyl-β-cyclodextrin: Improved physicochemical properties and anti-skin cancer activity.
    Hu SC; Lai YC; Lin CL; Tzeng WS; Yen FL
    Phytomedicine; 2019 Apr; 57():174-182. PubMed ID: 30776588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.
    Tajika T; Isowaki A; Sakaki H
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
    Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema.
    Nakano S; Yamamoto T; Kirii E; Abe S; Yamashita H
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):805-10. PubMed ID: 20180131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process.
    Bandi N; Wei W; Roberts CB; Kotra LP; Kompella UB
    Eur J Pharm Sci; 2004 Oct; 23(2):159-68. PubMed ID: 15451004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexation of oxethazaine with 2-hydroxypropyl-β-cyclodextrin: increased drug solubility, decreased cytotoxicity and analgesia at inflamed tissues.
    Prado AR; Yokaichiya F; Franco MKKD; Silva CMGD; Oliveira-Nascimento L; Franz-Montan M; Volpato MC; Cabeça LF; de Paula E
    J Pharm Pharmacol; 2017 Jun; 69(6):652-662. PubMed ID: 28211640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
    Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
    J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
    Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
    Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®).
    Quantz K; Anderson AL; Harman CD; Noland EL; Del Valle JM; Occelli LM; Burn JB; Petersen-Jones SM; Langlois DK; Pirie CG; Petersen AD; Komáromy AM
    BMC Vet Res; 2021 Dec; 17(1):366. PubMed ID: 34847929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.